Beth Zelnick Kaufman - 23 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Legal Officer
Signature
/s/ Beth Zelnick Kaufman
Issuer symbol
CRMD
Transactions as of
23 Jan 2026
Net transactions value
-$63,998
Form type
4
Filing time
27 Jan 2026, 21:30:55 UTC
Previous filing
06 Jan 2026
Next filing
06 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zelnick Kaufman Beth Chief Legal Officer C/O CORMEDIX INC.,, 389 INTERPACE PKWY, SUITE 450, PARSIPPANY /s/ Beth Zelnick Kaufman 27 Jan 2026 0002004480

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Award $0 +72,820 +43% $0.000000 241,905 23 Jan 2026 Direct F1
transaction CRMD Common Stock Tax liability $63,998 -8,803 -3.6% $7.27 233,102 23 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Remarks:

Exhibit 24.1 - Power of Attorney